SBC Medical Group (NASDAQ:SBC – Get Free Report) was downgraded by equities researchers at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Saturday, Wall Street Zen reports.
SBC has been the topic of a number of other reports. Weiss Ratings raised shares of SBC Medical Group from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, October 9th. BTIG Research reissued a “buy” rating and set a $8.00 target price on shares of SBC Medical Group in a research note on Thursday, August 13th. One research analyst has rated the stock with a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, SBC Medical Group has a consensus rating of “Moderate Buy” and an average target price of $8.00.
Get Our Latest Report on SBC Medical Group
SBC Medical Group Price Performance
Shares of SBC opened at $7.35 on Friday. The stock’s 50-day moving average price is $5.13 and its two-hundred day moving average price is $3.98. SBC Medical Group has a 12 month low of $2.78 and a 12 month high of $7.39. The company has a market capitalization of $755.93 million, a PE ratio of 14.70, a PEG ratio of 3.30 and a beta of 0.52. The company has a current ratio of 3.31, a quick ratio of 3.27 and a debt-to-equity ratio of 0.09.
SBC Medical Group (NASDAQ:SBC – Get Free Report) last posted its quarterly earnings data on Friday, November 13th. The company reported $0.15 EPS for the quarter, topping analysts’ consensus estimates of $0.12 by $0.03. SBC Medical Group had a return on equity of 19.14% and a net margin of 27.26%. The company had revenue of $58.58 million for the quarter, compared to analyst estimates of $48.90 million. On average, analysts anticipate that SBC Medical Group will post 0.44 EPS for the current year.
Institutional Investors Weigh In On SBC Medical Group
Several hedge funds and other institutional investors have recently bought and sold shares of SBC. Nisa Investment Advisors LLC acquired a new stake in shares of SBC Medical Group in the 3rd quarter valued at about $36,000. Bank of New York Mellon Corp bought a new stake in SBC Medical Group in the 1st quarter valued at about $43,000. Bank of America Corp DE acquired a new position in SBC Medical Group during the 2nd quarter worth approximately $35,000. Williams & Novak LLC raised its stake in SBC Medical Group by 31.2% during the 2nd quarter. Williams & Novak LLC now owns 18,686 shares of the company’s stock worth $58,000 after buying an additional 4,449 shares during the period. Finally, Deutsche Bank AG acquired a new position in SBC Medical Group during the 2nd quarter worth approximately $58,000. 60.82% of the stock is owned by institutional investors.
Top SBC Medical Group Stories
These are some of the SBC stories that stood out recently:
- Positive Sentiment: Third-quarter revenue rose 35% to $58.6 million, ahead of the $48.9 million analyst estimate. EPS of $0.15 also beat the $0.12 consensus. Net income attributable to SBC increased 22% to $15.7 million, while adjusted EBITDA rose 66% year over year. SBC Medical Group Holdings Reports Third Quarter 2026 Financial Results
- Positive Sentiment: Growth was supported by higher management-services revenue, service-fee revisions and the consolidation of Waqoo. The clinic network expanded to 293 locations, up 36 from a year earlier; the company reported $198.4 million in cash at quarter-end. SBC Medical Q3 Revenue Rises 35% to $58.6 Million
- Positive Sentiment: SBC announced a capital and business alliance with NeuroBrain Dynamics, a generative-AI company, with the stated goal of using medical AI to improve clinic profitability. The financial impact and rollout details were not disclosed. SBC Medical Announces Capital and Business Alliance with NeuroBrain Dynamics
SBC Medical Group Company Profile
SBC Medical Group Holdings provides management and support services to medical institutions, with a focus on clinics offering aesthetic medicine. Its services include support for clinic operations, marketing, staff training, procurement and customer service, allowing affiliated medical providers to focus on patient care. The group is associated with the Shonan Beauty Clinic brand and a broader network of clinics offering services such as cosmetic surgery and dermatology. Its business is centered primarily in Japan, where it supports the operations and growth of affiliated medical institutions.
Further Reading
- Five stocks we like better than SBC Medical Group
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for SBC Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SBC Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
